Latest News and Press Releases

BASEL, Switzerland, June 21, 2005 (PRIMEZONE) -- Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis, is extending its cash tender offer to acquire...

BASEL, Switzerland, June 7, 2005 (PRIMEZONE) -- Novartis (NYSE:NVS) announced today the completion of its acquisition of the generic pharmaceutical company Hexal AG in Germany on June 6. The...

-- Transforming the "grammar" of drug discovery by focusing on molecular pathways and patient stratification -- Redefining Research-to-Development transition through fast and rigorous...

-- Innovative, once-a-day oral formulation offers life-altering treatment option to broad range of iron overload patients -- Filings based on data from largest prospective clinical trials ...

- USD170 million financing commitment from Global Fund will help secure the majority of 2005-2006 Coartem supply - Novartis continues unprecedented production scale-up to meet rapidly...

BASEL, Switzerland, April 21, 2005 (PRIMEZONE) -- Novartis (NYSE:NVS): Key figures First quarter Q1 2005 Q1 2004 % Change ...

Pre-planned analysis of progression-free survival as assessed by investigators achieved statistical significance while analysis of primary endpoint of progression-free survival assessed by...

-- Significantly broadened product portfolio -- One of the largest pipelines in industry covering most generic opportunities -- Best-in-class development teams with proven record of being...

-- Novel mechanism of action expected to enhance tear secretion and increase mucin levels covering conjunctiva and cornea -- Over 22 million patients visit ophthalmologists each year seeking...

BASEL, Switzerland, Jan. 20, 2005 (PRIMEZONE) --Novartis (NYSE:NVS): Pharmaceuticals, led by the innovative, fast-growing oncology and cardiology franchises, drives expansion with market share...